Holdings of Caligan Partners LP
23 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 80.9 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 85.7 %
- FR 14.3 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 21 | 1.1B $ | 85.72 % |
| FR | 2 | 190.4M $ | 14.28 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Liquidia Corp | 8,118,892 | 306.4M $ | |
| Abivax SA | 1,461,924 | 162.8M $ | |
| Revolution Medicines Inc | 1,652,808 | 160.7M $ | |
| Vaxcyte Inc | 2,060,719 | 119.7M $ | |
| Mineralys Therapeutics Inc | 2,772,654 | 75.1M $ | |
| Exelixis Inc | 1,553,262 | 66.6M $ | |
| Tango Therapeutics Inc | 2,408,798 | 50.4M $ | |
| Tyra Biosciences Inc | 1,276,968 | 48.9M $ | |
| Spyre Therapeutics Inc | 878,127 | 44.3M $ | |
| ADMA Biologics Inc | 4,756,511 | 42.9M $ | |
| LB Pharmaceuticals Inc | 1,438,070 | 34.6M $ | |
| Vor BioPharma Inc | 1,925,066 | 34.3M $ | |
| SAB Biotherapeutics Inc | 7,967,207 | 30.5M $ | |
| Opus Genetics Inc | 6,075,028 | 27.6M $ | |
| Inventiva SACA | 4,974,906 | 27.6M $ | |
| MBX Biosciences Inc | 848,590 | 25.3M $ | |
| AVALO THERAPEUTICS INC | 1,635,023 | 24.4M $ | |
| Anika Therapeutics Inc | 1,435,130 | 20.8M $ | |
| Maze Therapeutics Inc | 614,962 | 18.4M $ | |
| Verrica Pharmaceuticals Inc | 923,910 | 4.9M $ | |
| SENSEI BIOTHERAPEUTICS INC | 126,002 | 4M $ | |
| Aura Biosciences Inc | 229,864 | 1.5M $ | |
| Xilio Therapeutics Inc | 112,128 | 943K $ |